Ryo Tsunashima

Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients

Yasuto Naoi, Kazuki Kishi, Tomonori Tanei et al. · Breast Cancer Research and Treatment · 2010 · 57 citations

Powerful Predictor, Oncology, Engineering +9

Construction of novel immune-related signature for prediction of pathological complete response to neoadjuvant chemotherapy in human breast cancer

Yoshiaki Sota, Yasuto Naoi, Ryo Tsunashima et al. · Annals of Oncology · 2013 · 51 citations

Breast Oncology, Cancer Immunosurveillance, Novel Immune-related Signature +11

Prediction of pathologic complete response to sequential paclitaxel and 5‐fluorouracil/epirubicin/cyclophosphamide therapy using a 70‐gene classifier for breast cancers

Yasuto Naoi, Kazuki Kishi, Tomonori Tanei et al. · Cancer · 2011 · 37 citations · Full text

Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients

Yasuto Naoi, Kazuki Kishi, Ryo Tsunashima et al. · Breast Cancer Research and Treatment · 2013 · 29 citations

Breast Oncology, Oncotype Dx, Medicine +9

MDM2 SNP309 and TP53 R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamide

Masatsugu Okishiro, Seung Jin Kim, Ryo Tsunashima et al. · Breast Cancer Research and Treatment · 2011 · 26 citations

Breast Oncology, Breast Cancer Patients, Medicine +8